Cardiovascular Disease

ZEUS – Effects of ziltivekimab versus placebo on cardiovascular outcomes in participants with established atherosclerotic cardiovascular disease, chronic kidney disease and systemic inflammation

Schedule an Appointment

Select an appointment date and time from available spots listed below.